Monogram Orthopaedics (MGRM) Competitors $5.45 -0.01 (-0.18%) Closing price 04:00 PM EasternExtended Trading$5.43 -0.02 (-0.37%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRM vs. BBNX, TNDM, AXGN, SIBN, BVS, ZIMV, AVNS, SMLR, KIDS, and CBLLShould you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include Beta Bionics (BBNX), Tandem Diabetes Care (TNDM), AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), ZimVie (ZIMV), Avanos Medical (AVNS), Semler Scientific (SMLR), OrthoPediatrics (KIDS), and CeriBell (CBLL). These companies are all part of the "medical equipment" industry. Monogram Orthopaedics vs. Its Competitors Beta Bionics Tandem Diabetes Care AxoGen SiBone Bioventus ZimVie Avanos Medical Semler Scientific OrthoPediatrics CeriBell Beta Bionics (NASDAQ:BBNX) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk. Do institutionals and insiders hold more shares of BBNX or MGRM? 0.5% of Monogram Orthopaedics shares are owned by institutional investors. 28.1% of Monogram Orthopaedics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media refer more to BBNX or MGRM? In the previous week, Monogram Orthopaedics had 3 more articles in the media than Beta Bionics. MarketBeat recorded 12 mentions for Monogram Orthopaedics and 9 mentions for Beta Bionics. Beta Bionics' average media sentiment score of 0.44 beat Monogram Orthopaedics' score of 0.18 indicating that Beta Bionics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Monogram Orthopaedics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is BBNX or MGRM more profitable? Beta Bionics' return on equity of 0.00% beat Monogram Orthopaedics' return on equity.Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A Monogram Orthopaedics N/A -126.82%-96.87% Which has better earnings & valuation, BBNX or MGRM? Monogram Orthopaedics has lower revenue, but higher earnings than Beta Bionics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$65.12M11.38-$54.76MN/AN/AMonogram Orthopaedics$370K598.47-$16.33M-$0.50-10.90 Do analysts rate BBNX or MGRM? Beta Bionics presently has a consensus price target of $22.56, suggesting a potential upside of 32.29%. Monogram Orthopaedics has a consensus price target of $5.40, suggesting a potential downside of 0.92%. Given Beta Bionics' higher possible upside, research analysts plainly believe Beta Bionics is more favorable than Monogram Orthopaedics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 0 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.75Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryBeta Bionics and Monogram Orthopaedics tied by winning 6 of the 12 factors compared between the two stocks. Get Monogram Orthopaedics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRM vs. The Competition Export to ExcelMetricMonogram OrthopaedicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$221.85M$6.88B$5.76B$9.58BDividend YieldN/A1.31%4.41%4.09%P/E Ratio-10.9027.4531.1026.05Price / Sales598.4775.30436.12105.98Price / CashN/A21.3437.7358.48Price / Book25.956.889.536.61Net Income-$16.33M$176.42M$3.26B$265.56M7 Day Performance2.25%0.58%2.11%1.98%1 Month Performance-4.89%-0.45%5.12%1.33%1 Year Performance60.29%13.07%31.25%21.15% Monogram Orthopaedics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRMMonogram Orthopaedics1.8228 of 5 stars$5.45-0.2%$5.40-0.9%+64.5%$221.85M$370K-10.9028Trending NewsEarnings ReportShort Interest ↓Analyst RevisionBBNXBeta Bionics2.6633 of 5 stars$17.26+1.3%$22.56+30.7%N/A$740.73M$65.12M0.00294News CoveragePositive NewsInsider TradeTNDMTandem Diabetes Care4.6029 of 5 stars$10.84+0.2%$22.67+109.1%-74.1%$731.10M$940.20M-3.512,650Analyst ForecastAXGNAxoGen3.0378 of 5 stars$15.49+3.8%$26.00+67.9%+22.6%$686.97M$203.27M-154.88450Short Interest ↑SIBNSiBone4.1865 of 5 stars$15.54+0.5%$23.67+52.3%+3.6%$670.41M$185.26M-27.75350News CoverageInsider TradeBVSBioventus1.0234 of 5 stars$7.18-2.6%N/AN/A$609.34M$573.28M14.741,200ZIMVZimVie0.7222 of 5 stars$18.95+0.5%$17.75-6.3%+9.6%$531.59M$449.75M-27.071,770Positive NewsShort Interest ↑AVNSAvanos Medical3.3111 of 5 stars$11.24+0.4%N/A-52.0%$522.02M$692.50M-1.122,227Short Interest ↑SMLRSemler Scientific3.6261 of 5 stars$33.76-0.2%$81.75+142.2%+2.5%$500.99M$56.29M13.89120KIDSOrthoPediatrics3.955 of 5 stars$19.20+0.1%$34.14+77.8%-39.1%$481.17M$220.73M-10.73200CBLLCeriBell2.3845 of 5 stars$12.18-1.1%$32.14+163.9%N/A$451.33M$65.44M-4.07N/A Related Companies and Tools Related Companies Beta Bionics Competitors Tandem Diabetes Care Competitors AxoGen Competitors SiBone Competitors Bioventus Competitors ZimVie Competitors Avanos Medical Competitors Semler Scientific Competitors OrthoPediatrics Competitors CeriBell Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRM) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monogram Orthopaedics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monogram Orthopaedics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access